Heart Valve Technology

This channel includes news and new device innovations about heart valve technologies, including the aortic valve, mitral valve, pulmonic valve, and tricuspid valve. This includes information on transcatheter valve technologies like transcatheter aortic valve replacement (TAVR, or implantation TAVI), transcatheter mitral valve repair or replacement (TMVR), transcatheter and surgical valve repairs, and surgical replacement valves. Newer devices are now being used for transcatheter tricuspid valve repair replacement (TTVR). 

News

January 26, 2012 — Heart Hospital of Austin opened a heart valve clinic, the first of its kind in the region. The clinic ...

Home January 26, 2012
Home
News

January 25, 2012 — Which Medical Device announced the winner of its Device of the Year Award 2011 in the cardiology ...

Home January 25, 2012
Home
News

January 17, 2012 – Terumo Americas Holding Inc., a U.S. subsidiary of Japan's Terumo Corp., announced it acquired Onset ...

Home January 17, 2012
Home
News

January 4, 2012 – ECRI, an independent nonprofit that researches the best approaches to improving patient care, listed ...

Home January 04, 2012
Home
News

December 28, 2011 – Edwards Lifesciences announced two-year results of a pivotal clinical study of inoperable patients ...

Home December 28, 2011
Home
News

December 23, 2011 - Philips Healthcare said Medical City Dallas Hospital, Dallas, Texas, is the first hospital in the ...

Home December 23, 2011
Home
Blog

Each year that I attend Transcatheter Cardiovascular Therapeutics (TCT), I comb the event and its sessions looking ...

Home December 20, 2011
Home
Feature | Julie McLaughlin, Senior Analyst, Millennium Research Group

Transcatheter aortic valve repair (TAVR) — also commonly referred to as transcatheter aortic valve implantation (TAVI) — ...

Home November 22, 2011
Home
Whitepapers | Samir Kapadia, Heart and Vascular Institute Cleveland

Patient History
72-year-old, male patient with previously placed bioprosthetic mitral valve.
 

Diagnosis
Mitral ...

Home November 21, 2011
Home
Feature | Dave Fornell

Each year that I attend Transcatheter Cardiovascular Therapeutics (TCT), I comb the event and its sessions looking for ...

Home November 17, 2011
Home
News

November 15, 2011 — A two-year study of patients in the landmark PARTNER trial confirms the one-year findings and ...

Home November 15, 2011
Home
News

 

November 15, 2011 – Results of the PARTNER Cohort A QOL study demonstrate that transcatheter aortic valve replacement ...

Home November 15, 2011
Home
News

November 14, 2011 — Edwards Lifesciences Corp. announced data were presented on the quality of life impact and cost ...

Home November 14, 2011
Home
News

November 10, 2011 — The results of an analysis of 149 EVEREST II high surgical risk patients with significant mitral ...

Home November 10, 2011
Home
News

November 10, 2011 — Edwards Lifesciences Corp. announced the U.S. Food and Drug Administration (FDA) conditionally ...

Home November 10, 2011
Home
Subscribe Now